In Wednesday’s Wall Street session, Helius Medical Technologies Inc (NASDAQ:HSDT) shares traded at $0.36, up 16.38% from the previous session.
HSDT stock price is now -89.76% away from the 50-day moving average and -95.19% away from the 200-day moving average. The market capitalization of the company currently stands at $0.19M.
With the price target of $20, Noble Capital Markets recently initiated with Outperform rating for Helius Medical Technologies Inc (NASDAQ: HSDT).
A total of 5.46% of the company’s stock is owned by insiders.
During the past 12 months, Helius Medical Technologies Inc has had a low of $0.30 and a high of $24.00. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 1.69, and a quick ratio of 1.13. The fifty day moving average price for HSDT is $3.5185 and a two-hundred day moving average price translates $7.48375 for the stock.
The latest earnings results from Helius Medical Technologies Inc (NASDAQ: HSDT) was released for 2025-03-31. The net profit margin was -3010.14% and return on equity was -800.00% for HSDT. The company reported revenue of $49000.0 for the quarter, compared to $0.14 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -63.7 percent.
